Variable HIV peptide stability in human cytosol is critical to epitope presentation and immune escape.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 21555856.
- Also identified by DOI 10.1172/JCI44932 and PMC identifier 3104749.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Induction of virus-specific CD8⁺ T cell responses is critical for the success of vaccines against chronic viral infections. Despite the large number of potential MHC-I-restricted epitopes located in viral proteins, MHC-I-restricted epitope generation is inefficient, and factors defining the production and presentation of MHC-I-restricted viral epitopes are poorly understood. Here, we have demonstrated that the half-lives of HIV-derived peptides in cytosol from primary human cells were highly variable and sequence dependent, and significantly affected the efficiency of cell recognition by CD8⁺ T cells. Furthermore, multiple clinical isolates of HLA-associated HIV epitope variants displayed reduced half-lives relative to consensus sequence. This decreased cytosolic peptide stability diminished epitope presentation and CTL recognition, illustrating a mechanism of immune escape. Chaperone complexes including Hsp90 and histone deacetylase HDAC6 enhanced peptide stability by transient protection from peptidase degradation. Based on empirical results with 166 peptides, we developed a computational approach utilizing a sequence-based algorithm to estimate the cytosolic stability of antigenic peptides. Our results identify sequence motifs able to alter the amount of peptide available for loading onto MHC-I, suggesting potential new strategies to modulate epitope production from vaccine immunogens.
Medical subject headings
- Antigen Presentation
- Epitopes
- HIV Antigens
- HIV Core Protein p24
- HIV Reverse Transcriptase
- HIV-1
- T-Cell Antigen Receptor Specificity
- T-Lymphocytes, Cytotoxic
- gag Gene Products, Human Immunodeficiency Virus